X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Clinical and Translational Medicine

期刊標題檢索 CLIN TRANSL MED 最新評論: The editorial processing speed is still very fast, with initial review... (2026-02-26)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Clinical and Translational Medicine]您好,您是該頁面的第 104026 位訪客。

期刊簡介
期刊名稱Clinical and Translational Medicine Clinical and Translational Medicine
LetPub Score
8.0
52 ratings
Rate

Reputation
9.4

Influence
7.1

Speed
7.3

期刊簡稱CLIN TRANSL MED
ISSN2001-1326
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
33.802.7811.989
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Medicine (miscellaneous)
Q13 / 466
Category: Medicine
Subcategory: Molecular Medicine
Q14 / 179

自引率 (2023-2024)1.30%自引率趨勢
掲載範囲
Clinical and Translational Medicine (CTM) is an international, peer-reviewed, and open access journal with aims at promoting and accelerating the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. The journal emphasizes clinical potential and application of new biotechnologies, biomaterials, bioengineering, disease-specific biomarkers, cellular and molecular medicine, omics science, bioinformatics, applied immunology, molecular imaging, drug discovery and development,and regulation and health policy. The journal is
focused on the bench to bedside approach, favoring studies and clinical observations which generate hypotheses and questions relevant to the patient
and disease, and guide the investigations of cellular and molecular medicine. Clinical and Translational Medicine welcomes submissions from clinicians, researchers, policy makers, and the industry.

Clinical and Translational Medicine (CTM) 是同行评审的国际开放获取期刊,旨在促进临床前研究向临床应用的转化,加强基础科学家和临床科学家之间的交流。本期刊侧重于新生物技术、生物材料、生物工程、疾病特异性生物标志物、细胞和分子医学、组学科学、生物信息学、应用免疫学、分子成像、药物发现和开发以及监管和卫生政策。本期刊聚焦从实验室到临床的方法,青睐可以提出与患者和疾病相关的假设和问题的研究与临床观察,并对细胞和分子医学研究提供指导。Clinical and Translational Medicine欢迎临床医生、研究人员、政策制定者和业内人士投稿。
官方網站https://onlinelibrary.wiley.com/journal/20011326
在線稿件提交https://mc.manuscriptcentral.com/ctm2
開放訪問Yes
出版商Wiley
主題領域Multiple
出版國/地區ENGLAND
發行頻率月刊
創刊年2012
每年文章數315每年文章數趨勢
黃金OA百分比100.00%
OA Related Info
APC: Yes( USD3300; GBP2550; EUR2860; )
APC waiver:Check Notes
Other charges: No
Keywords: disease-specific biomarkers、omics science、bioinformatics、applied immunology、molecular medicine
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ125/191
ONCOLOGYSCIEQ145/333
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2001-1326%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 4 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Clinical and Translational Medicine】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 649.80
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 159.20
    LANCETH-index: 700

    CiteScore: 92.40
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 74.80
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 126.60
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 71.30
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 96.20
    MMWR Recommendations and ReportsH-index: 0

    CiteScore: 131.20
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 83.50
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 26.00
    學科內最受檢索的期刊 頁面查看次數
    PHARMACEUTICAL BIOLOGY23307881
    Frontiers in Pharmacology6575867
    Oncology Letters1618045
    BIOMATERIALS1578518
    Cancer Medicine1076074
    Oncogenesis1007886
    JOURNAL OF ETHNOPHARMACOLOGY725965
    Archives of Medical Science719325
    MEDICINE707692
    Frontiers in Oncology598866
  •  

    Clinical and Translational Medicine Clinical and Translational Medicine
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [Clinical and Translational Medicine] 的評論撰寫評論
作者: 温和的常常


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2026-02-26 11:39:57 評論於
The editorial processing speed is still very fast, with initial review and second review basically controlled within 3 weeks. I have published 2 articles in this journal, both of which were reviewed by 4 reviewers. I have also been rejected twice in the past, with an overall publication rate of 50%.
(0) 讚! | 温和的常常

作者: 投稿必中罗大大


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2025-09-10 16:52:38 評論於
Under Review means internal audit, which takes quite a long time, nearly half a month.
(0) 讚! | 投稿必中罗大大

作者: 投稿必中罗大大


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2025-09-10 08:47:54 評論於
After submitting my work, it was rejected half a month later, leaving me happy for half a month.
(0) 讚! | 投稿必中罗大大

作者: ellen707


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2025-09-08 18:08:11 評論於
Is it an external audit or an internal audit in the same situation?
(0) 讚! | ellen707

作者: 投稿必中罗大大


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-08-26 08:55:54 評論於
I am the same. Shortly after submitting the article, it went "Under Review" {in less than a day}. I wonder if this is external review or internal review?
(0) 讚! | 投稿必中罗大大

作者: 天问


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2025-08-12 10:48:30 評論於
After submitting the manuscript, it was sent for external review the next day, and returned after about 20 days. There were three reviewers who raised more than 20 questions, which were quite professional. The revised manuscript was sent back two months later, and returned after about 20 days for a second review, with two additional reviewers. The manuscript was revised again one week later, and accepted seven days after the third round of review. It was published one week later. The review process was relatively fast, with articles typically being published within a month, and the quality of the articles is quite good.
(0) 讚! | 天问

作者: 茯苓-


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-06-03 13:03:12 評論於
Me too, is this situation for review?
(0) 讚! | 茯苓-

作者: ICAR2023


領域: 工程技术
審稿時間: 1.0 month(s)
結果: 直接被接受


撰寫評論

2025-04-29 10:23:25 評論於
I can't understand why a civil engineering professional like me was invited to review a journal in JCR Zone 1 and the top journals of the Chinese Academy of Sciences. It's even more suspicious that I have been invited more than once.
(1) 讚! | ICAR2023

作者: Zhan Chen


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2025-03-18 09:49:04 評論於
Is there a timeline? Is this "Under Review" an internal or external review? The detailed information on the left states "This submission is under consideration and cannot be edited. Further information will be emailed to you by the journal editorial office."
(0) 讚! | Zhan Chen

作者: DDDZ


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2023-10-23 20:32:14 評論於
After submission, four reviewers were invited for the first review, among whom two had very critical comments. The paper underwent two rounds of revisions, and an additional reviewer was brought in during one of the revisions. The overall feedback was professional. It was a challenging process, but thankfully the paper was eventually published
(3) 讚! | DDDZ

作者: 小小华07


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2023-01-17 17:36:31 評論於
The submitted manuscript was rejected within a week, and the magazine's handling was very fast.
Both the magazine's homepage and the submission system have been changed. The latest submission address is: https://mc.manuscriptcentral.com/ctm2. The homepage address is: https://onlinelibrary.wiley.com/journal/20011326.
(0) 讚! | 小小华07

作者: 394jdk3kd


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2021-10-09 00:05:35 評論於
How long after receiving can it be published?
(0) 讚! | 394jdk3kd

作者: B.I.G


領域: 生物学
審稿時間: 8.0 month(s)
結果: 修改後接受


撰寫評論

2021-06-25 10:07:10 評論於
At the beginning of the year, I submitted an article for review by 5 reviewers, with a total of 52 major and minor issues. The impact factor for 2020 is 10 points, which means the requirements for the manuscript are very high. I heard that currently it is being sent to 6-7 reviewers. The review process takes about a month. The publication fee is around 3000 USD, which is considered reasonable for a 10-point journal.
(5) 讚! | B.I.G

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [Clinical and Translational Medicine] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*